EU regulator accepts Sanofi/Regeneron's Dupixent product for review
December 08, 2016 at 01:22 AM EST
PARIS, Dec 8 (Reuters) - The European Medicines Agency (EMA), the European Union's health regulator, has accepted for review the Dupixent product being developed by drugmakers Sanofi and Regeneron, the companies said on Thursday.
